1. Home
  2. BLZE vs DNA Comparison

BLZE vs DNA Comparison

Compare BLZE & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

N/A

Current Price

$8.01

Market Cap

762.0M

Sector

Technology

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$12.83

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLZE
DNA
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
762.0M
835.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BLZE
DNA
Price
$8.01
$12.83
Analyst Decision
Buy
Sell
Analyst Count
7
3
Target Price
★ $21.50
$8.00
AVG Volume (30 Days)
★ 2.9M
2.4M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
46.49
EPS
★ N/A
N/A
Revenue
$145,835,000.00
★ $170,155,000.00
Revenue This Year
$22.06
N/A
Revenue Next Year
$24.74
$13.05
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$5.37
52 Week High
$23.99
$18.22

Technical Indicators

Market Signals
Indicator
BLZE
DNA
Relative Strength Index (RSI) 36.90 56.28
Support Level $6.82 $6.75
Resistance Level $8.42 $13.97
Average True Range (ATR) 0.76 1.37
MACD 0.09 -0.01
Stochastic Oscillator 43.00 66.95

Price Performance

Historical Comparison
BLZE
DNA

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: